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Fast axonal transport (FAT) requires consistent
energy over long distances to fuel the molecular
motors that transport vesicles. We demonstrate
that glycolysis provides ATP for the FAT of vesicles.
Although inhibiting ATP production from mitochon-
dria did not affect vesicles motility, pharmacological
or genetic inhibition of the glycolytic enzyme GAPDH
reduced transport in cultured neurons and in
Drosophila larvae. GAPDH localizes on vesicles via
a huntingtin-dependent mechanism and is trans-
ported on fast-moving vesicles within axons. Purified
motile vesicles showed GAPDH enzymatic activity
and produced ATP. Finally, we show that vesicular
GAPDH is necessary and sufficient to provide on-
board energy for fast vesicular transport. Although
detaching GAPDH from vesicles reduced transport,
targeting GAPDH to vesicles was sufficient to pro-
mote FAT in GAPDH deficient neurons. This specifi-
cally localized glycolytic machinery may supply
constant energy, independent of mitochondria,
for the processive movement of vesicles over long
distances in axons.
INTRODUCTION
Fast axonal transport (FAT) is mediated by the molecular motors
dynein and kinesin that transport cargos over long distances in
neurons (Hirokawa et al., 2010). This extremely rapid and effi-
cient transport is essential to deliver molecules such as trophic
factors to nerve terminals that can be distant up to 1 m from
cell bodies in the case of human motor neurons (Salinas et al.,
2008). FAT consumes energy because the dynein and kinesin
motors require ATP to transport cargos along microtubules.
Because kinesin hydrolyses one ATP per 8 nm step (Gennerichand Vale, 2009), nerve cells must have energy sources distrib-
uted throughout their axons for these molecular motors to
function.
Glucose is the major source of brain energy and is required for
normal brain function. Glucose breakdown occurs in the cytosol
through the glycolytic pathway that converts glucose into pyru-
vate and generates free energy (Ames, 2000). The net energetic
balance of glycolysis is relatively low, with two ATP being
produced from one molecule of glucose. In contrast to glycol-
ysis, mitochondria produce 34 ATP molecules (Ames, 2000)
and provide most of the energy used by the brain. However,
mitochondria are not evenly distributed within neurons, and are
most abundant at sites with a high-energy demand such as
synapses and nodes of Ranvier (MacAskill and Kittler, 2010).
One fundamental requirement for efficient FAT is a constant
supply of ATP. How is ATP distributed within neurons to fuel
the molecular motors? It also remains to be understood how
ATP can be continuously provided to fast-moving vesicles in
axonal segments devoid of mitochondria. These questions
are of particular importance in the context of several neurode-
generative disorders, such as amyotrophic lateral sclerosis,
Alzheimer’s, Parkinson’s, and Huntington’s diseases, which
are characterized by mitochondrial dysfunction and axonal
transport defects (Hirokawa et al., 2010; Salinas et al., 2008).
Here we investigated the relative contributions of glycolysis
and themitochondrial respiratory chain in supplying ATP for FAT.
RESULTS
Mitochondria, GAPDH, and Axonal ATP
To reliably analyze vesicular FAT, we designed microfluidic-
based devices derived from a previously described microfluidic
culture platform (Taylor et al., 2005). Embryonic rat cortical
neurons can extend long processes into the channels, but only
axons can reach the distal chamber located 450 mm away from
the proximal chamber containing the cell bodies and most
of the dendrites, as shown by Tau staining (Figure S1A
available online). We electroporated cortical neurons withCell 152, 479–491, January 31, 2013 ª2013 Elsevier Inc. 479
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Figure 1. Microfluidic Device to Analyze
Transport and ATP Content in Axons
(A) Transport of BDNF-mCherry in rat cortical
axons. The top picture is a time projection of BDNF
that reveals the presence of several axons in the
microchannel. Top middle corresponds to the
generated kymograph. Analyzed trajectories are
shown with a color code, green for anterograde,
red for retrograde, and blue for static vesicles.
Bottom illustrates the distribution of velocity from
ten analyzed kymographs (anterograde n = 174,
retrograde n = 154).
(B) Rat cortical neurons expressing Mito-DR and
GAPDH-eGFP. Top is an overlaid picture taken in
the cell body chamber compartment and middle
shows the distal part of the channel with two axons
(differential interference contrast [DIC] in gray,
Mito-DR in red, and GAPDH-eGFP in green).
Bottom is a two-color kymograph.
(C) Rat cortical neurons expressing Perceval. pH
reporter SNARF 5 was added to the medium and
chambers were analyzed with confocal micros-
copy. Upper (1) DIC, reveals axons in the channel.
SNARF5 labeling reveals two axons that were
analyzed for their intracellular pH (2) and normal-
ized to the isobastic point (iso, 3). The upper axon
in the chamber shows high expression of Perceval
that was used to analyze ADP (4) and ATP (5). The
ADP, ATP overlay is shown in (o, 6).
(D) Perceval signal reveals small fluctuations of the
ATP:ADP ratio within axons whereas the pH ratio
remained constant.
See also Figure S1.fluorescent-tagged cargos and plated the neurons in micro-
chambers. We performed FAT assays 3–5 days after the cells
were plated, when axons had reached the distal chamber. We
used brain-derived neurotrophic factor tagged with mCherry
(BDNF-mCherry), which displays the characteristic features of
a FAT-dependent cargo and retains BDNF function (Kwinter
et al., 2009). To selectively analyze axonal transport, we re-
corded vesicular dynamics in the distal part of themicrochannels
and generated kymographs from the video recordings. Analyzes
of BDNF vesicle dynamics revealed fast and highly processive
anterograde and retrograde movements (Figure 1A; Movie S1)
at velocities similar to those previously reported (Kwinter et al.,
2009).
To analyze the distribution of mitochondria and of the key
glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) in the microfluidic devices, we used a mitochondrial
signal peptide fused to dsRed (Mito-DR) and GAPDH tagged
with GFP (GADPH-GFP) and verified that the respective behav-
iors of these constructs in axons grown in microchannels were
similar to that in cultured neurons. As previously reported (Miller480 Cell 152, 479–491, January 31, 2013 ª2013 Elsevier Inc.and Sheetz, 2004; Tristan et al., 2011),
mitochondria were abundant in cell
bodies and discontinuously distributed in
neurites, whereas GAPDH was diffused
throughout the cytoplasm (Figure 1B).
The same pattern of distribution wasobserved in axons extending within the microchannels (Fig-
ure 1B). Mitochondria exhibited characteristic dynamic behavior
within the microchambers, and were either stationary, very
dynamic, or changing directions (Movie S2) as illustrated by
the two-color kymograph (Figure 1B). We also investigated the
trafficking of BDNF-mCherry-containing vesicles and of mito-
chondria in the same axons and found no overlap between
stationary or dynamic populations (Figure S1B). In contrast to
mitochondria, GAPDH was diffuse throughout the cytosol of
the chambered axons and its distribution did not appear to
change over time (Figure 1B).
Although there are many reliable methods to measure ATP
content within cells, the subcellular location of ATP is more diffi-
cult to resolve. To selectively determine changes in ATP content
within axons, we took advantage of a genetically encoded fluo-
rescent sensor that monitors ATP:ADP ratio in living cells (Berg
et al., 2009). The ATP:ADP ratio was constant over long
distances within the axons (Figures 1C and 1D). As the signal
emitted by Perceval is pH-dependent, we measured possible
variations in intracellular pH using the SNARF 5 probe and
observed no major fluctuations throughout the axons. This
suggests that there is a constant availability in ATP within axons
that is provided by both mitochondria and glycolysis.
GAPDH but Not Mitochondria Is Critical for FAT
We next determined whether mitochondrial H+-ATP-synthase
inhibition by oligomycin, which blocks ATP production from the
mitochondria (Chang and Reynolds, 2006), or whether GAPDH
inhibition by iodoacetate affected FAT in cultured cortical
neurons. We first measured the efficacy of oligomycin and
iodoacetate in modulating ATP content within neurons. We
added 1 mM pyruvate to the iodoacetate-treated neurons to
bypass glycolysis and to allow mitochondria to continue to
produce ATP. A 5min treatment with oligomycin (20 mM) induced
a 25% reduction in ATP that reached to 80% after 30 min (Fig-
ure 2A). In contrast, a 30 min iodoacetate treatment that leads
to a strong inhibition of GAPDH (Figure 2B) reduced ATP by
only 40%. We next measured ATP:ADP ratio using Perceval as
in Figure 1A. We observed a dynamic response in the Perceval
signal that correlated with the ATP content as measured within
neuronal extracts. Oligomycin treatment produced a progressive
and substantial reduction in the Perceval signal, whereas iodoa-
cetate treatment was not as effective (Figure 2C). These results
indicate that most of the ATP in neurons originated from the
mitochondria and that mitochondria inhibition rather than
GAPDH inhibition significantly reduced the ATP level in neurons.
We next assessed BDNF vesicle dynamics in these condi-
tions. After 30 min oligomycin treatment, when ATP is maximally
reduced (Figure 2A), mean anterograde and retrograde vesicle
velocity was unaffected and the percentage of dynamic vesicles
remained constant (Figures 2D and S2A). We next treated
neurons with iodoacetate and pyruvate. In contrast to oligomy-
cin-mediated inhibition of mitochondrial ATP, GAPDH inhibition
reduced FAT of BDNF vesicles after as little as 5 min of iodoace-
tate treatment as shown in the kymograph and by the reduction
in the velocities and dynamics of BDNF (Figures 2D and S2A;
Movie S1). In support for a specific effect of iodoacetate, we
found a 50% inhibition of FAT when using its IC50 concentration
(Schmidt and Dringen, 2009) (Figure S2B).
Although oligomycin had no effect on vesicle transport, it
rapidly blocked mitochondria trafficking (Figures 2E and S2C;
Movie S2). On the other hand, iodoacetate had no effect onmito-
chondria dynamics even after 30min of treatment. This indicates
the lack of off-target effects of iodoacetate on molecular motors
because the same motors are used for mitochondria and vesi-
cles (Hirokawa et al., 2010). These results are in agreement
with previous studies indicating that loss of mitochondrial ATP
production, but not the disruption of mitochondrial membrane
potential or mitochondria morphology can induce the loss of
mitochondria dynamics (Kaasik et al., 2007; Rintoul et al.,
2003). Together, these experiments suggest that GAPDH rather
than mitochondria is critical for FAT.
We next took advantage of the identification of two mitochon-
dria adaptor proteins, milton and Miro (Glater et al., 2006; Wang
and Schwarz, 2009), to specifically deplete mitochondria from
axons and redistribute them into the cell bodies. Indeed, milton
knockout flies show no mitochondria in their axons but have
a normal axonal distribution of vesicles. This suggested thattransport of vesicles may not strictly depend on mitochondria.
Previous work showed that milton-C expression in neurons
redistributes mitochondria into the cell bodies but does not alter
mitochondria function (Glater et al., 2006). We therefore
expressed milton-C in cortical neurons and observed that mito-
chondria clustered within cell bodies so that axons were
depleted of mitochondria (Figure 3A). By transfecting Perceval
into neurons, we observed a progressive but marked reduction
of ATP:ADP ratio within axons of neurons coexpressing milton-
C whereas the ratio in the cell body remained high (Figure 3B).
We next coexpressed milton-C, GFP, and mito-DR in neurons
and plated them in microchambers. Having verified that mito-
chondria were also absent from axons in microchannels as
a result of milton-C expression (Figure 3C), we assessed BDNF
vesicle dynamics in neurons expressing milton-C and BDNF-
mCherry. To make sure these axons are depleted from mito-
chondria, we added mitotracker to the medium and recorded
vesicular transport in the distal part of the mitochondria-
depleted axons. We found that the velocities of vesicles were
largely unaffected (Figure 3D) compared to control neurons (Fig-
ure 1A). Our results indicate that BDNF vesicles can move effi-
ciently in axons both devoid of mitochondria and with reduced
ATP:ADP ratio.
Silencing GAPDH Impairs FAT of BDNF, APP, and TrkB
but Not Mitochondria Trafficking
We plated on coverslips cortical neurons silenced for GAPDH
with a siRNA that specifically targets rat GAPDHmRNA. GAPDH
knockdown substantially reduced GAPDH protein levels as
shown by immunoblot analyzes (Figure 4A). We observed
a significant reduction in both anterograde and retrograde trans-
port of BDNF vesicles in GAPDH-silenced neurons (Figures 4B
and 4C). We also silenced GAPDHwith another siRNA sequence
in cortical neurons that were plated in microchambers (Fig-
ure S3A). As with the first siRNA (Figures 4A–4C), we observed
a significant decrease in transport (Figures S3B and S3C). To
verify the efficacy of the two siRNAs, we determined GAPDH
activity and protein levels and observed a similar reduction (Fig-
ure S3D). Finally, to control for any possible off-target effects, we
restored GADPH protein levels in siRNA-treated neurons by co-
expressing a mouse GAPDH-GFP construct that was insensitive
to the rat GAPDH siRNA (Figure 4A). We observed a complete
recovery of normal BDNF vesicle dynamics in axons (Figures
4B and 4C).
Besides its role in glycolysis, GAPDH functions in other cellular
processes such as DNA repair, membrane fusion, cytoskeletal
dynamics, and cell death (Tristan et al., 2011). To demonstrate
that the inhibitory effect of silencing GAPDH on FAT is linked to
its glycolytic activity, we coexpressed a siRNA-insensitive and
catalytically inactive form of GADPH (GAPDH-GFP-C149G) (Fig-
ure 4A). In contrast to GAPDH-GFP, the catalytically inactive
construct was unable to restore the defective axonal transport
induced by the siRNA (Figures 4B and 4C). These results indicate
that catalytically active GAPDH is required for FAT and that the
mechanism involves sustained glycolytic activity.
We next analyzed the consequences of GAPDH silencing on
the transport of other cargos. As for iodoacetate treatment we
found no effect on mitochondria dynamics (Figure 4D) furtherCell 152, 479–491, January 31, 2013 ª2013 Elsevier Inc. 481
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Figure 2. Inhibition of GAPDH Reduces BDNF Transport but Inhibition of Mitochondrial ATP Synthesis Does Not
(A and B) Cortical rat neurons were treated with 20 mM oligomycin or 1 mM iodoacetate and 1 mM pyruvate for five and 30 min. Total ATP level (A) and GAPDH
activity (B) were recorded and expressed as percentages of the values found in untreated cultures (control) (n = 8).
(C) Time course of Perceval ratio measured in neurons treated or not with oligomycin or iodoacetate.
(D) Neurons expressing BDNF-mCherry plated in microchambers were treated with oligomycin or iodoacetate and pyruvate as in (A). Representative kymograph
of BDNF, mean + SEM for anterograde and retrograde velocities and for the percentage of dynamics vesicles in control, 30 min oligomycin- and, 5 min
(legend continued on next page)
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A Figure 3. Milton-C Depletes Mitochondria
from Axons and Induces an ATP:ADP Ratio
Drop in Axons but Does Not Affect FAT
(A) Rat cortical neurons expressing Mito-DR, GFP,
and empty control vector (pcDNA) or milton-C
were analyzed by confocal microscopy. Mito-
chondria arepresent in thecell body, dendrites and
axon of control neurons. In most milton-C ex-
pressing neurons, mitochondria are clustered in
thecell bodyandabsent fromdendrites andaxons.
(B) Neurons expressing Perceval and, empty
control vector (pcDNA) or milton-C. Pseudocolor
reveals the ATP:ADP distribution along the axons.
Quantification of the ATP:ADP signal along the
axons was performed using a line-scan from the
cell body through the axon. The graph corre-
sponds to themeandrop ofATP:ADP ratio in axons
when neurons express milton-C (n = 3 axons).
(C) DIC picture of milton-C, GFP, and Mito-DR
expressing neurons plated in microchambers with
the axon entering the channel. No mitochondria
were found in the axon.
(D) Neurons expressing BDNF-mCherry and
milton-C with mitotracker green to stain mito-
chondria. In contrast to the top axon, the bottom
one (*) has no mitochondria and was recorded for
BDNF trafficking. The kymograph (bottom) and
the quantification of anterograde and retrograde
velocities (mean + SEM, anterograde vesicles n =
28, retrograde vesicles n = 17) revealed typical
FAT values.indicating that mitochondria transport does not depend on
GAPDH. We then investigated two other types of cargos: the
amyloid-precursor protein APP fused to GFP (APP-GFP), a
characteristic marker of FAT in neurons whose transport is
kinesin-1-dependent (Kaether et al., 2000) and TrkB, the BDNF
receptor fused to RFP (TrkB-RFP) that is trafficked bidirectionally
within axons (Salinas et al., 2008). Whereas, APP and TrkB-
containing vesicles motilities were not modified upon oligomycin
treatment (Figure S3E), we observed a marked reduction in the
transport of both cargos after GAPDH silencing (Figures 4E
and 4F) suggesting that GAPDH could participate to the trans-
port of many different types of vesicles.
In Vivo Silencing of GAPDH Reduces FAT in Drosophila
Larvae
Because glycolysis may have a preferentially predominant role in
providing ATP in cultured neurons, we determined the conse-
quences of GAPDH depletion on in vivo axonal transport in
Drosophila melanogaster. We exploited the transparency of the
larvae to record axonal transport (Pilling et al., 2006). Larvae at
L3 stage were placed between two coverslips and examined
by videomicroscopy (Figures 4G and 4H). We used the UAS-
GAL4 system to express synaptotagmin-GFP in the segmentaliodoacetate-treated neurons (anterograde velocity, control: n = 275; oligomycin:
40; iodoacetate: n = 10; percentages of dynamic vesicles were calculated from r
(E) Neurons expressing Mito-DR plated in microchambers were treated with olig
Mito-DR, mean + SEM for anterograde and retrograde velocities and for the pe
iodoacetate-treated neurons (anterograde velocity, control: n = 44; oligomycin: n
iodoacetate: n = 50; percentages of dynamic vesicles were calculated from resp
*p < 0.5, ***p < 0.001. Error bars represent SEM. See also Figure S2, and Moviesnerves of Drosophila using the Ok6-Gal4 driver. We crossed
these flies with UAS-shGAPDH flies to selectively deplete
GAPDH in the motoneurons of the offspring. As control, we
crossed the synaptotagmin-GFP flies to UAS-shZPG flies (see
Extended Experimental Procedures). We observed a strong
reduction in the velocity of synaptotagmin-GFP vesicles trans-
port in flies expressing shGAPDH compared to that in flies ex-
pressing the shZPG (Figure 4I; Movie S3). The use of another
UAS-shGAPDH Drosophila (shGAPDH(2)) line gave similar
results (Figure 4I). We also found that the dynamics of mitochon-
dria were not altered in flies that are silenced for GAPDH.
(Figure 4J). This further demonstrates in vivo our findings that
transport of vesicles depends on GAPDH whereas transport of
mitochondria does not.
Together, our results in cortical neurons and in Drosophila
larvae demonstrate that (1) GAPDH is required for FAT in vitro
and in vivo, (2) this mechanismmight be general, and (3) this crit-
ical function has been evolutionarily conserved.
GAPDH Localizes on Vesicles
Although GAPDH is mainly cytosolic, it has also been reported to
be in specific subcellular compartments including the cytoskel-
eton, membranes, and fusion vesicles (Tristan et al., 2011).n = 46; iodoacetate: n = 5; retrograde velocity, control: n = 235; oligomycin: n =
espectively 13 (control), 7 (oligomycin) and 16 (iodoacetate) kymographs).
omycin or iodoacetate and pyruvate as in (A). Representative kymographs of
rcentage of dynamic mitochondria in control, 5 min oligomycin- and 30 min
= 7; iodoacetate: n = 46; retrograde velocity, control: n = 51; oligomycin: n = 4;
ectively 7 (control), 10 (oligomycin) and 14 (iodoacetate) kymographs).
S1 and S2.
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Figure 4. GAPDH Silencing In Rat Neurons
and In Vivo Reduces FAT of Vesicles but
Not of Mitochondria
A) Immunoblot of rat cortical neurons extracts
showing GAPDH gene-replacement with mouse
GAPDH-GFP.
(B) Rat neurons were electroporated as in (A) to
replace endogenous GAPDH expression, together
with the BDNF-mCherry vector and plated on
coverslips. Kymographs were generated.
(C) Quantification of mean velocities from kymo-
graphs. These experiments were not performed in
microchambers. The values represent neuritic
velocities (axons and dendrites) that are generally
lower than pure axonal velocities (anterograde:
scramble siRNA [sc] + pcDNA: n = 75; siGAPDH +
pcDNA: n = 290; siGAPDH + GAPDH-GFP: n =
184; siGAPDH + GAPDH-GFP-C149G: n = 136;
retrograde: sc + pcDNA: n = 50; siGAPDH +
pcDNA: n = 296; siGAPDH + GAPDH-GFP: n =
136; siGAPDH + GAPDH-GFP-C149G: n = 123).
(D) Mean velocity of Mito-DR-labeled mitochon-
dria in axons with sc or siGAPDH (anterograde: sc:
n = 67; siGAPDH: n = 129; retrograde: sc: n = 82;
siGAPDH: n = 144).
(E) Mean velocity of APP-GFP vesicles in axons
with sc or siGAPDH (anterograde: sc: n = 440;
siGAPDH II: n = 338; retrograde: sc: n = 415;
siGAPDH II: n = 329).
(F) Mean velocity of TrkB-RFP in axons with sc or
siGAPDH (anterograde: sc: n = 328; siGAPDH II:
n = 220; retrograde: sc: n = 212; siGAPDH II:
n = 191).
(G) Drosophila L3 larvae expressing synapto-
tagmin-GFP and shZPG (control) or shGAPDH in
all motor neurons were collected and processed
for videomicroscopy as illustrated.
(H) Low and high magnifications of confocal
microscopy images of a synaptotagmin-GFP L3
larva. The green channel corresponds to GFP
(488 nm) and the red channel to larva auto-
fluorescence at 561 nm.
(I) Characteristic kymographs of synaptotagmin-
GFP are shown as well as the quantification of
mean vesicles velocity (left: n = 30 for shZPG and
n = 27 for shGAPDH [3] and right: n = 64 forwt and
n = 68 for shGAPDH [2] flies).
(J) Quantification of Mito-GFP mean velocity in
control (shZPG) and shGAPDH (3) larvae (n = 35
for shZPG and n = 35 for shGAPDH [3] flies).
***p < 0.001. Error bars represent SEM. See also
Figure S3 and Movie S3.Therefore we analyzed whether GAPDH is located on brain vesi-
cles. We performed subcellular fractionation of mouse brain and
found GAPDH in the ‘‘small vesicles’’ fraction (P3) that also con-
tained synaptophysin, BDNF and the p50 and p150 subunits of
dynactin. We also detected dynein intermediate chain (DIC)
and kinesin heavy chain (KHC) that are subunits of the corre-
sponding molecular motors, dynein and kinesin-1 (Figures 5A
and S4). We next performed immunofluorescence experiments
for endogenous GAPDH on neurons that were electroporated
with BDNF-mCherry. We first permeabilized cells with saponin
before fixation to remove the abundant cytosolic pool of GAPDH484 Cell 152, 479–491, January 31, 2013 ª2013 Elsevier Inc.and selectively detect vesicle-associated GAPDH. We found
a strong colocalization of endogenous GAPDH on BDNF-con-
taining vesicles along axons as shown by confocal microscopy
and reconstruction along the z axis. Quantification of the coloc-
alization revealed a strong overlap between BDNF vesicles and
GAPDH (Figure 5B) with 77.2% ± 7.6% of BDNF vesicles being
positive for endogenous GAPDH (n = 102).
To further demonstrate that GAPDH is present on ‘‘motile vesi-
cles’’ and has a functional role, we adapted a previously reported
protocol (Perlson et al., 2009) to purify dynamic vesicles from the
brains of Thy1-p50-GFP transgenic mice (M30 line) that express
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Figure 5. GAPDH Localizes on Motile Vesi-
cles
(A) Adult mouse brains were processed to obtain
different subcellular fractions as illustrated in Fig-
ure S4 (cytosolic [S3], vesicular [P3], and cytosol +
vesicles fraction [S2]) that were subsequently
analyzed by immunoblotting.
(B) Confocal images of cortical axons with BDNF-
mCherry vesicles and immunostained for endog-
enous GAPDH.
(C) Immunoblotting analyzes of the motile vesicles
preparation (IP), as illustrated in Figure S4. VF,
vesicles fraction; IP, immunopurified vesicles; FT,
flow through.
(D) Purification and staining process of motile
vesicles. Native motile vesicles were stained with
DIO (green) and immunostained for endogenous
GAPDH (top row). Control condition is without first
antibody (bottom row).
(E) (a) Immunocryoelectron microscopy reveals
the presence of GAPDH antigens on the vesicle
(black dots). (b) Negative control without anti-
GAPDH antibody. (c) Representation of a tomo-
gram projection (10 slices) computed from a 3D
reconstruction of a GAPDH immunogold-labeled
vesicle. (d) Color representation of the 3D volume
of (c). Blue pixels depict the vesicle, reddish
pixels show iron bead used for vesicles purifica-
tion and yellow pixels correspond to the IgG-
conjugated gold particle. Analysis of micrographies revealed an average number of gold particles associated to vesicles of 0.2 ± 0.2 for negative control
and 1.1 ± 0.5 for immunolabeled sample (p < 0.05).
See also Movie S4 and Figure S4.the p50 dynamitin subunit of dynactin fused to GFP under the
Thy1 neuronal promoter. These mice express p50-GFP at low
concentration so that it does not disrupt the dynactin complex
and thereby does not alter axonal transport (Ross et al., 2006).
We first performed a subcellular fractionation of the brain tissue
and obtained a cytoplasmic fraction containing small organelles,
which we then subjected to sucrose gradient purification to
enrich for vesicles (VF) (Figures 5C and S4). This fraction con-
tained GAPDH, endogenous p50, the transgenic p50-GFP, and
thep150dynactin subunit. ThisVF fractionalsocontainedsoluble
proteins as shown by the presence of significant levels of tubulin.
We next used an anti-GFP antibody to selectively immunopurify
vesicles containing p50-GFP, which therefore represented
neuronal motile vesicles (IP lane, Figures 5C and S4). This immu-
nomagneticpurificationof neuronal vesiclescontaining themotor
complexeswas effective as the IP fractionwasgreatly enriched in
p50-GFPprotein andeliminated soluble proteins as shownby the
near to complete absence of tubulin in the IP fraction. In addition,
no proteins were detected by BCA assay, Coomassie-stained
gels or immunoblots from immunomagnetic purifications of non-
transgenicmouse brains (data not shown). This indicates the lack
of contamination by soluble proteins. The IP fraction contained
BDNF, SNAP25, a vesicular protein, and components of the
molecular motors complex such as DIC, endogenous p50, the
p150 dynactin subunit, and low levels of kinesin. This is expected
as a significant fraction of kinesin is in the cytosol and kinesin is
recruited to vesicles upon activation (Figure 5A) (Colin et al.,
2008). This method therefore allowed us to highly purify vesiclesthat contain p50-GFP and themolecular motors complex, aswell
as proteins associated to these motile vesicles. Importantly,
GAPDH was present in the IP fraction (Figure 5C). As phospho-
glycerate kinase (PGK) is downstream of GAPDH and generates
ATP during glycolysis, we tested whether PGK was also present
with GAPDH on the vesicles. Like GAPDH, we also found PGK in
the small vesicles fraction (Figure 5A) and in the immunopurified
motile vesicles fraction (Figure 5C). Dynabeads coupled to
anti-GFP antibodies were used to purify native intact vesicles
from the vesicle fraction (VF) that were then labeled with a lipo-
philic marker (Figures 5D and S4). These motile vesicles were
immunopositive for GAPDH (Figure 5D) suggesting localization
of GAPDH on the cytosolic face of the vesicles. To unequivocally
demonstrate GAPDH localization, we performed immunocryo-
electron tomography and found a significant number of gold
particles on vesicles in presenceofGAPDHantibodies compared
to the situation without primary antibody (Figure 5E, a and b;
Movie S4). 3D reconstruction of tilt series and 3D volume
rendering demonstrated the localization of GAPDH on the cyto-
solic face of the vesicles (Figure 5E, c and d; Movie S4).
Motile Vesicles Show GAPDH Activity and Produce ATP
We next investigated the role of vesicular GAPDH. First, purified
motile vesicles were capable of substantial GAPDH activity (Fig-
ure 6A). Next, we incubated the motile vesicles fraction (IP) with
glyceraldehyde-3-phosphate, ADP, Pi, and NAD+ to measure
ATP production (Figure 6B). We observed a rapid and significant
production of ATP under these conditions showing that bothCell 152, 479–491, January 31, 2013 ª2013 Elsevier Inc. 485
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Figure 6. Motile Vesicles Produce ATP and
Vesicular GAPDH Is Sufficient for FAT
(A) GAPDH activity ofmotile vesicles is inhibited by
iodoacetate (n = 6).
(B) Motile vesicles fraction incubated with glyco-
lytic substrates shows ATP production (n = 3).
(C) Cortical neurons expressing GAPDH-GFP
were plated in the microchambers and fluores-
cence was analyzed by confocal microscopy. The
axon was photobleached prior to video recording.
Stars indicate fast-moving GAPDH-GFP-positive
vesicles. The corresponding kymograph is shown.
(D) Cortical neurons expressing GAPDH-GFP and
BDNF-mCherry were analyzed as in (C). The
kymograph shows cotransport of the two proteins
in axons.
(E) Cartoon showing the chimeric Synapto-
tagmin1-TM-GAPDH-GFP protein.
(F) Axons of neurons expressing BDNF-mCherry
together with TM-GAPDH-GFP were analyzed by
confocal microscopy.
(G) Immunoblotting of HEK cells expressing
various constructs of active, inactive and vesicular
GAPDH and fractionated as in Figure 5A.
(H) Velocity of BDNF vesicles in neurons electro-
porated with sc or siGAPDH and with active or
inactive TM-GAPDH-GFP and plated in micro-
chambers. (anterograde: scramble siRNA (sc) +
GFP: n = 10; siGAPDH II + GFP: n = 43; siGAPDH
II + TM-GAPDH-GFP: n = 108; siGAPDH II + TM-
GAPDH-C149G-GFP: n = 31; retrograde: scram-
ble siRNA (sc) + GFP: n = 11; siGAPDH II + GFP:
n = 51; siGAPDH II + TM-GAPDH-GFP: n = 70;
siGAPDH II + TM-GAPDH-C149G-GFP: n = 30).
*p < 0.5, **p < 0.01,***p < 0.001. Error bars
represent SEM. See also Movies S5 and S6 and
Figure S4.GAPDH and the downstream PGK are enzymatically active. ATP
production required full GAPDH catalytic function, as it was
completely blocked by iodoacetate. These results show that
motile vesicles contain functional glycolytic machinery and
produce ATP in an autonomous manner.
Vesicular GAPDH Is Transported within Axons
We next expressed GAPDH-GFP in cortical neurons and used
videomicroscopy to analyze axons for the presence of
GAPDH-GFP-labeled dynamic vesicles. As GAPDH is mainly
cytosolic, we first bleached the axon within the microchannel
to extinguish existing fluorescence. We observed fast-moving
GAPDH-GFP-positive vesicles with high processive movements486 Cell 152, 479–491, January 31, 2013 ª2013 Elsevier Inc.(Movie S5; Figure 6C). To further demon-
strate that GAPDH is present on fast-
moving vesicles, we determined whether
GAPDH-GFP and BDNF-mCherry were
being cotransported on the same vesi-
cles. As shown by the movie and kymo-
graph analyzes (Movie S6; Figure 6D),
most of the dynamic vesicles containing
BDNF-mCherry were also positive forGAPDH-GFP.We could also detect dynamic GAPDH-GFP-posi-
tive vesicles that were negative for BDNF-mCherry supporting
a wider role of GAPDH in the transport of other vesicles such
as synaptotagmin, APP, and TrkB-containing vesicles (Figure 4).
The findings that GAPDH is present on motile vesicles that are
actively transported in axons suggest that vesicular GAPDH
could provide energy support for axonal transport.
Vesicular GAPDH Is Sufficient to Promote FAT of
Vesicles
To unequivocally address whether vesicular GAPDH is sufficient
for FAT we silenced endogenous GAPDH and addressed
GAPDH to vesicles through its fusion to the transmembrane
domain of synaptotagmin (Figure 6E). The fusion protein called
TM-GAPDH-GFP colocalized with BDNF-mCherry vesicles in
axons (Figure 6F). Quantification of the colocalization revealed
a strong overlap between BDNF vesicles and GAPDH with
72.2% ± 2.4% of BDNF vesicles found positive for TM-GAPDH
(n = 326). TM-GAPDH-GFP was also detected in the vesicular
fraction after subcellular fractionation (Figure 6G). However, in
contrast to wild-type GAPDH and GAPDH-GFP, TM-GAPDH
was not detected in the cytosol (S3 fraction, Figure 6G). Re-
expressing TM-GAPDH in neurons silenced for endogenous
GAPDH was found sufficient to restore axonal transport. In
contrast, a catalytically inactive vesicular GAPDH (C149G) was
unable to restore axonal transport in these conditions (Figure 6H).
These results indicate that a strictly vesicular GAPDH is sufficient
to propel vesicles in axons.
Huntingtin Scaffolds GAPDH on Vesicles
To investigate the requirement of GAPDH on vesicles for FAT, we
searched for themechanism(s) that maintain GAPDH on vesicles
with the goal of blocking GAPDH attachment to vesicles and
analyzing axonal transport. Identifying such a mechanism would
add further evidence for the specificity and the physiological
relevance of GAPDH localization on vesicles.
GAPDH interacts with huntingtin (HTT), the protein that when
mutated causes Huntington’s disease (Bae et al., 2006; Burke
et al., 1996; Culver et al., 2012; Goehler et al., 2004; Kaltenbach
et al., 2007; Ratovitski et al., 2012). HTT localizes on vesicles and
is an essential scaffold protein regulating axonal transport of
vesicles including BDNF (Caviston and Holzbaur, 2009; Colin
et al., 2008; Gauthier et al., 2004). We detected HTT in the motile
vesicle fraction with GAPDH (Figure 5C). We immunostained
neurons electroporated with BDNF-eGFP for endogenous HTT
and GAPDH and selectively assessed the pool of vesicular asso-
ciated proteins by saponin treatment. Both proteins colocalized
within axons on BDNF vesicles (Figure 7A). To investigate
whether HTT could scaffold GAPDH on vesicles, we silenced
HTT using previously characterized siRNA that show no off-
target effects (Colin et al., 2008). We observed a loss of GAPDH
localization on BDNF vesicles (Figure 7B). We confirmed these
findings in vivo by crossing Httflox/flox mice (Dragatsis et al.,
2000) with the inducible CamKII-CreERT2 line that express the
CRE recombinase in the cortex and hippocampus upon tamox-
ifen treatment (see Extended Experimental Procedures) and per-
formed subcellular fractionation from their cortices (Figure 7C).
This successfully reduced HTT in all fractions. However, the
GAPDH levels were only decreased in the vesicular fraction
(P3) demonstrating that depletion of HTT reduces GAPDH
attachment to vesicles. These results agree with the observation
that HTT is a phenocopy of GAPDH because the silencing of
either protein decreases the transport of BDNF, APP, and TrkB
(Colin et al., 2008; Gauthier et al., 2004; G.L., unpublished
data) (Figure 4F). Our findings also provide further evidence for
the specific localization of GAPDH on vesicles.
Vesicular GAPDH Is Necessary to Promote FAT
of Vesicles
Our finding that HTT depletion leads to the detachment of
GAPDH from vesicles but maintains GAPDH pool in the cytosolallowed us to address whether vesicular GAPDH is necessary
to propel vesicles within axons. Therefore, we selectively
decreased vesicular GAPDH by depleting HTT in cortical
neurons and analyzed FAT (Figures 7D and 7E). We used two
siRNA targeting different sequences of HTT and found that
both RNAi decreased FAT when compared to scramble siRNA.
The observed decrease in transport was similar to that of
GAPDH-silenced neurons (Figures 4C and 6H). We re-ex-
pressed TM-GAPDH in HTT-silenced neurons and found that
for both siHTT used, TM-GAPDH rescued axonal transport in
both directions. Interestingly, forcing the vesicular localization
of GAPDH on vesicles further increased the anterograde velocity
of the vesicles compared to the control condition (GFP) or the
C149G inactive point mutant (Figure 7F). This suggests that
increasing the stoichiometry of GAPDH and consequently the
local energy supply on vesicles further enhances the efficacy
of transport. Together, we conclude that vesicular but not cyto-
solic GAPDH is required to propel vesicles at high velocities in
axons.
DISCUSSION
We show that glycolytic enzymes located on vesicles rather
than mitochondria are critical to maintain the high vesicular
velocities that are characteristic of FAT. Perturbing glycolysis
decreases FAT but does not totally block transport. Conversely,
we found that FAT does not depend on the ATP generated by
the mitochondria. However, our findings do not exclude the
possibility that mitochondria could insure a basic transport
within cells.
GAPDH is a very abundant protein present both in the cyto-
plasm and the nucleus and is also reported to interact with
microtubules and membranes (Tristan et al., 2011). Could
GAPDH present on MTs contribute to generate ATP for FAT of
vesicles? The exact function of GAPDH on MTs is not fully
understood, but GAPDH was shown to induce MT bundling
(Huitorel and Pantaloni, 1985). However, binding of the enzymat-
ically active tetrameric form of GAPDH to MTs leads to its disso-
ciation into a monomeric and inactive enzyme (Durrieu et al.,
1987) suggesting a low glycolytic activity of GAPDHwhen bound
to MTs. Another function for GAPDH on MTs could be linked to
its vesicle fusion activity. Indeed, evidence suggests a role for
GAPDH in the fusion of vesicles to membranes (Glaser and
Gross, 1995; Tisdale, 2002) but this GAPDH-dependent
membrane fusion is independent from its glycolytic activity
(Tisdale et al., 2004). Although we cannot exclude the possibility
that MT-associated GAPDH could contribute to FAT, our
findings that glycolytic enzymes are present on motile vesicles
and produce ATP and, that a strictly vesicular GAPDH is neces-
sary and sufficient to propel vesicles at high velocities in
GAPDH-silenced neurons suggest that molecular motors could
use preferentially this local pool of ATP generated by the vesicle
itself.
Because GAPDH localizes on fast moving vesicles within
axons, what are the possible mechanisms linking GAPDH to
vesicular membranes? We have found that HTT, the protein
that when mutated causes Huntington’s disease, scaffolds
GAPDH on vesicles. Our findings are in agreement with theCell 152, 479–491, January 31, 2013 ª2013 Elsevier Inc. 487
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Figure 7. Vesicular GAPDH Is Required for FAT
(A) Immunostaining of endogenous HTT and endogenous GAPDH of cortical neurons electroporated with BDNF-mCherry and scramble siRNA were analyzed by
confocal microscopy. The arrows show the axon that was resliced along the z axis (on the right).
(B) Neurons were silenced for HTT (siHTT) and processed as in (A).
(C) Immunoblotting of adult cortices from Httflox/flox and CamKCreERT2;Httflox/flox mice previously fractionated as in Figure 5A. The quantification corresponds to
five animals per genotype.
(D) Cortical neurons electroporated with sc or two different siHTT and GFP or TM-GAPDH-GFP were analyzed by immunoblotting for endogenous HTT, GAPDH,
and tubulin.
(E) Velocity of BDNF vesicles in neurons plated inmicrochambers electroporated as in (D). (anterograde: scramble siRNA (sc) + GFP: n = 35; siHTT I + GFP: n = 23;
siHTT I + TM-GAPDH-GFP: n = 46; siHTT II + GFP: n = 61; siHTT II + TM-GAPDH-GFP: n = 91; retrograde: scramble siRNA (sc) + GFP: n = 39; siHTT I + GFP:
n = 16; siHTT I + TM-GAPDH-GFP: n = 36; siHTT II + GFP: n = 68; siHTT II + TM-GAPDH-GFP: n = 91).
(F) Velocity of BDNF vesicles in neurons plated in microchambers electroporated with GFP, active or inactive TM-GAPDH-GFP. (anterograde: GFP: n = 169;
TM-GAPDH-GFP: n = 280; TM-GAPDH-C149G-GFP: n = 260; retrograde: GFP: n = 117; TM-GAPDH-GFP: n = 187; TM-GAPDH-C149G-GFP: n = 287).
*p < 0.5, ***p < 0.001, Error bars represent SEM.
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many studies that reported an interaction between HTT and
GAPDH (Bae et al., 2006; Burke et al., 1996; Culver et al.,
2012; Goehler et al., 2004; Kaltenbach et al., 2007; Ratovitski
et al., 2012; Shirasaki et al., 2012). We also found PGK on the
motile fraction. Whether HTT also scaffolds other key enzymes
of the glycolytic pathway such as PGK remains to be determined
although this may be a possibility given the identification of such
enzymes by proteomic or yeast two-hybrid approaches (Culver
et al., 2012; Kaltenbach et al., 2007; Shirasaki et al., 2012)
Also, it will be of interest to determine whether such scaffolding
function is altered in Huntington’s disease. Such studies may
shed light on the mechanisms by which HTT regulates axonal
transport in Huntington’s disease and reconcile the defects in
axonal transport and the observed defects in energetic
homeostasis.
Although we show a crucial role for HTT in GAPDH attachment
to vesicles, it is still possible that other mechanisms coexist.
Indeed, the Rab2 GTPase that is required for protein transport
within the early secretory pathway binds to and recruits GAPDH
to vesicular membranes (Tisdale et al., 2004). Similarly to the
transport from the endoplasmic reticulum to Golgi, specific
Rabs that remain to be identified could recruit GAPDH onto
fast moving vesicles in axons. Another mechanism for the vesic-
ular recruitment of GAPDH could involve posttranslational modi-
fications of GAPDH, such as palmitoylation at cysteine 244 that
was shown to increase recruitment of GAPDH to vesicles (Yang
et al., 2005).
The local vesicular ATP production by the glycolytic enzymes
and its consumption by the molecular motors present on the
same vesicles may provide rapid feedback between ATP
production and changes in consumption, as has been shown
in erythrocytes (Ames, 2000). This concept of vesicular ener-
getic coupling is also supported by a proteomic study that
identified GAPDH and PGK on synaptic vesicles (Burre´ and
Volknandt, 2007) and by the observation that glycolytic
machinery activates the vesicular proton pump required for
vesicle glutamate reuptake at the synapse (Ikemoto et al.,
2003). In addition, our results show that contrary to vesicular
transport, mitochondrial traffic does not rely on glycolysis,
but depends on mitochondrial ATP. Although similar to vesic-
ular motors, the motors that transport mitochondria preferen-
tially use ATP produced by the mitochondria rather than ATP
generated by nonmitochondrial sources, such as the cyto-
plasmic glycolytic machinery. How the same motors—kinesin-1
is involved in the transport of both mitochondria and vesicles
(Hirokawa et al., 2010)—discriminate between these dif-
ferent sources of ATP is likely to depend on the proximity of
the energetic source and ensures the full efficacy of the cellular
system.
In neurons, mitochondria are scattered in axons but enriched
at subcellular locations that require high energy levels, such as
synapses and nodes of Ranvier. Thus, along an axon, mitochon-
dria can thereby be spared and may even be absent from large
regions. Our findings that glycolytic machinery is present on
fast-moving vesicles in axons indicate that neurons have con-
structed an autonomous transport system that is independent
of the fluctuating energy levels that could occur in some regions
of the axon.EXPERIMENTAL PROCEDURES
Mice
All experimental procedures were performed in strict accordance with
the recommendations of the European Community (86/609/EEC) and
the French National Committee (87/848) for care and use of laboratory
animals.
Flies
Recombinant ok6-Gal4:UAS-Syt-GFP (X) flies and CCAP-G4/CyOA-G;UAS-
mitoGFP/TM3SAG flies are gifts from M.-L. Parmentier and T. Schwarz,
respectively. UAS-shGAPDH and UAS-shZPG strains were provided
by Vienna Drosophila RNAi Center (VDRC). Generation of crosses and
in vivo transport assay in fly larvae are detailed in Extended Experimental
Procedures.
Microchambers and Neurons Plating
Microchambers were made according to Taylor et al. (2005). For videomicro-
scopy or immunostaining, we first electroporated cortical neurons with
fluorescent-tagged cargos and plated the neurons in microchambers. Micro-
chambers fabrication and electroporation are detailed in Extended Experi-
mental Procedures.
Videomicroscopy and Video Analyses
Live videomicroscopy of neuronal cultures or Drosophila larvae were carried
out using an imaging system previously detailed (Gauthier et al., 2004).
Videomicroscopy and video analyses are detailed in Extended Experimental
Procedures.
Immunoisolation of Vesicles and Immunocryoelectron Tomography
We selectively purified vesicles that contain p50-GFP from Thy:p50-GFP
mouse brains (Ross et al., 2006) through successive subcellular fractionation,
sucrose gradient fractionation, and immunoisolation. Vesicles were either
immunostained in native conditions and analyzed by confocal microscopy or
processed for immunocryoelectron tomography (Extended Experimental
Procedures).
Perceval Assay, GAPDH Activity, and ATP Production
Neurons expressing Perceval were analyzed by Leica SP5 laser scanning
confocal microscope. Perceval signal was quantified as the ratio of
the ATP/ADP channels and controlled for pH variations (Extended Experi-
mental Procedures). GAPDH activity was measured using the KDalert GAPDH
Assay (Invitrogen). ATP production was measured using the CellTiter-Glo
Luminescent Viability Assay (Promega) as detailed in Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and six movies and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.12.029.
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